LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...
T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.
It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback